Lore Gruenbaum Announces the Blood Cancer United Discovery Grant Program 2026–2027
Lore Gruenbaum, Chief Scientific Officer at Blood Cancer United, shared a post on LinkedIn: “We are delighted to announce that our Blood Cancer United Discovery Grant Program is now open for […]
Read the full articleYou might also wanna read
New cancer biology and therapeutics PhD program approved at UMMC
jennastanley Fri, 07/10/2026 - 01:14 PM
La junta directiva de OHSU inaugura la era del Knight Cancer Group con aprobación y estructura de gobierno
Una nueva estructura le da al Knight Cancer Institute mayor autoridad y autonomía para crear una experiencia para pacientes de la más alta c
New cancer biology and therapeutics PhD program approved at UMMC
jennastanley Fri, 07/10/2026 - 12:25 PM
BHVN Stock Builds Momentum Ahead Of Multiple H2 2026 Clinical Data Readouts
The company is expected to announce clinical data for hard-to-treat epilepsy and obesity later this year.
Quarterly Highlights from the Health & Clinical Research and Life Sciences Communities (April to June 2026)
We’re halfway through 2026! It’s time to reflect on some popular posts shared across the Health & Clinical Research and Life Sciences Commun
The Precision Medicine Revolution: How Scientists Are Finally Seeing Cancer Clearly
Scientists worldwide are mapping cancer's hidden vulnerabilities—16 leukemia subgroups, a protein that unlocks solid tumors, and a yeast sup
Comments
Sign in to join the conversation.
No comments yet. Be the first.